The role of GABAB receptors in intracortical inhibition in the human motor cortex

被引:422
作者
McDonnell, Michelle N.
Orekhov, Yuri
Ziemann, Ulf [1 ]
机构
[1] Univ Frankfurt, Motor Cortex Lab, Dept Neurol, D-60528 Frankfurt, Germany
[2] Univ Adelaide, Res Ctr Human Movement Control, Adelaide, SA, Australia
关键词
baclofen; long interval intracortical inhibition; short interval intracortical inhibition; transcranial magnetic stimulation; human motor cortex;
D O I
10.1007/s00221-006-0365-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While GABA(B) receptors are thought to have an important role in mediating long interval intracortical inhibition (LICI) in the human motor cortex, the effect of a selective GABA(B) receptor agonist on this measure has not been directly tested. Nine healthy volunteers ingested either 50 mg baclofen (BAC) or placebo (PBO) in a randomized, double blind crossover design, with the second session one week later. We used transcranial magnetic stimulation to assess motor threshold, motor evoked potential (MEP) amplitude, cortical silent period (CSP) duration, short interval intracortical inhibition (SICI) and LICI before and 90 min following drug intake. There was no specific effect of drug on motor threshold, MEP amplitude or CSP duration. BAC resulted in a significant increase in LICI (P=0.002) and a significant decrease in SICI (P=0.046) while PBO had no effect. Our findings demonstrate that the enhanced GABA(B) receptor activation results in differential effects on these two measures of intracortical inhibition in the human motor cortex. The increase in LICI is likely to be a result of increased GABA(B) receptor mediated inhibitory post-synaptic potentials, while the reduction in SICI may relate to the activation of pre-synaptic GABA(B) receptors reducing GABA release.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 41 条
[1]   Functional and pharmacological properties of GABA-mediated inhibition in the human neocortex [J].
Avoli, M ;
Hwa, G ;
Louvel, J ;
Kurcewicz, I ;
Pumain, R ;
Lacaille, JC .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (05) :526-534
[2]   GABA-B RECEPTOR PHARMACOLOGY [J].
BOWERY, NG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :109-147
[3]   The role of GABA(B) mechanisms in animal models of absence seizures [J].
Caddick, SJ ;
Hosford, DA .
MOLECULAR NEUROBIOLOGY, 1996, 13 (01) :23-32
[4]   Mechanism of the silent period following transcranial magnetic stimulation - Evidence from epidural recordings [J].
Chen, R ;
Lozano, AM ;
Ashby, P .
EXPERIMENTAL BRAIN RESEARCH, 1999, 128 (04) :539-542
[5]   2 INHIBITORY POSTSYNAPTIC POTENTIALS, AND GABAA AND GABAB RECEPTOR-MEDIATED RESPONSES IN NEOCORTEX OF RAT AND CAT [J].
CONNORS, BW ;
MALENKA, RC ;
SILVA, LR .
JOURNAL OF PHYSIOLOGY-LONDON, 1988, 406 :443-468
[6]  
Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO
[7]  
2-D
[8]   The GABAB receptor antagonist CGP 55845A reduces presynaptic GABAB actions in neocortical neurons of the rat in vitro [J].
Deisz, RA .
NEUROSCIENCE, 1999, 93 (04) :1241-1249
[9]   GABAB receptor-mediated effects in human and rat neocortical neurones in vitro [J].
Deisz, RA .
NEUROPHARMACOLOGY, 1999, 38 (11) :1755-1766
[10]  
Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265